MARTINELLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 16.344
EU - Europa 13.979
AS - Asia 9.953
SA - Sud America 1.348
AF - Africa 233
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 19
Totale 41.900
Nazione #
US - Stati Uniti d'America 16.091
RU - Federazione Russa 5.066
SG - Singapore 4.149
GB - Regno Unito 3.114
CN - Cina 2.841
DE - Germania 1.118
BR - Brasile 1.088
IT - Italia 1.001
VN - Vietnam 882
FR - Francia 798
HK - Hong Kong 798
SE - Svezia 798
FI - Finlandia 741
IE - Irlanda 663
KR - Corea 335
UA - Ucraina 201
BD - Bangladesh 143
JP - Giappone 140
CA - Canada 136
IN - India 136
TR - Turchia 133
AR - Argentina 91
NL - Olanda 85
BE - Belgio 75
MX - Messico 68
ES - Italia 61
NG - Nigeria 60
IQ - Iraq 59
ID - Indonesia 58
PL - Polonia 54
ZA - Sudafrica 51
AT - Austria 44
PK - Pakistan 35
UZ - Uzbekistan 35
EC - Ecuador 32
CO - Colombia 29
CL - Cile 28
TN - Tunisia 24
VE - Venezuela 23
IL - Israele 22
MA - Marocco 22
SA - Arabia Saudita 21
AU - Australia 20
PE - Perù 20
GR - Grecia 18
EG - Egitto 17
JO - Giordania 16
IR - Iran 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 14
EU - Europa 14
KE - Kenya 14
PH - Filippine 14
PY - Paraguay 14
HR - Croazia 13
LT - Lituania 13
UY - Uruguay 13
DK - Danimarca 12
RO - Romania 12
AZ - Azerbaigian 11
HN - Honduras 10
JM - Giamaica 10
MY - Malesia 10
BJ - Benin 9
CZ - Repubblica Ceca 9
KG - Kirghizistan 9
KZ - Kazakistan 9
NP - Nepal 9
OM - Oman 8
AL - Albania 7
BO - Bolivia 7
BG - Bulgaria 6
BH - Bahrain 6
DZ - Algeria 6
ET - Etiopia 6
LB - Libano 6
LV - Lettonia 6
PS - Palestinian Territory 6
PT - Portogallo 6
RS - Serbia 6
BY - Bielorussia 5
CR - Costa Rica 5
LU - Lussemburgo 5
SN - Senegal 5
HU - Ungheria 4
LK - Sri Lanka 4
MT - Malta 4
NZ - Nuova Zelanda 4
PA - Panama 4
TH - Thailandia 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
MD - Moldavia 3
Totale 41.838
Città #
Southend 2.619
Singapore 2.285
Jacksonville 1.815
Chandler 1.644
Moscow 1.640
Ashburn 1.540
San Jose 1.441
Woodbridge 1.170
Dallas 1.085
Ann Arbor 858
Hong Kong 784
Dublin 657
Houston 563
Verona 518
The Dalles 453
Beijing 434
Council Bluffs 393
New York 367
Ho Chi Minh City 289
Lawrence 285
Princeton 285
Wilmington 269
Los Angeles 265
Nanjing 203
Helsinki 190
Hanoi 186
Jinan 185
Munich 170
Buffalo 149
Boardman 148
Shenyang 134
São Paulo 122
Tokyo 114
Santa Clara 113
Sindelfingen 111
Tianjin 98
Hebei 97
Redondo Beach 91
Orem 87
Columbus 84
Zhengzhou 81
Lancaster 77
Redmond 77
Brussels 75
Turku 75
Milan 74
Nanchang 73
Changsha 67
Haikou 56
Jiaxing 55
Abuja 54
Dong Ket 53
London 53
Montreal 53
San Francisco 53
Taiyuan 50
Seattle 48
Frankfurt am Main 47
Ningbo 47
Nürnberg 46
Hangzhou 44
Norwalk 44
Seoul 44
Chennai 43
Denver 43
Guangzhou 43
Washington 42
Warsaw 41
Toronto 40
Phoenix 39
Chicago 37
Da Nang 37
Johannesburg 37
Stockholm 37
Taizhou 37
Boston 36
Haiphong 36
Amsterdam 34
Atlanta 34
Manchester 34
Nuremberg 34
Brooklyn 32
Lanzhou 32
Vienna 31
Tashkent 30
Mexico City 28
Poplar 28
Rio de Janeiro 28
Jakarta 26
Kent 26
Redwood City 26
Shanghai 26
Dongguan 25
Falkenstein 25
Baghdad 24
Rome 23
Fuzhou 22
Padova 22
Paris 22
Ankara 20
Totale 26.467
Nome #
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 297
A 'desaturase hypothesis' for atherosclerosis: Janus-faced enzymes in omega-6 and omega-3 polyunsaturated fatty acid metabolism. 269
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 262
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 254
A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost 253
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 250
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 249
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 245
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 242
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 239
A1298C methylentetrahydrofolate reductase mutation and coronary artery disease:relationship with C677T polymorphysm and homocystein/folate metabolism 233
Associazione di polimorfismi del cluster dei geni FADS1 e FADS2 con i livelli di acidi grassi polinsaturi in malattie coronariche 230
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 225
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 224
NEXT GENERATION TARGETED DEEP SEQUENCING OF HEMOCHROMATOSIS GENES IN IRON OVERLOADED PATIENTS: A PILOT STUDY 224
Novel serum paraoxonase activity assays are associated with coronary artery disease 223
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 222
Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease 214
A common polymorphism in low-density lipoprotein receptor gene is a predictor of factor VIII activity levels and is associated with coronary artery disease. 212
Comparison of Topical Tacrolimus 0.1% in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe in desquamative gingivitis:a 4-week, randomized, double-blind clinical trial 210
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 209
Identification of a novel serological marker in seronegative Rheumatoid Arthritis using the peptide library approach. 208
Analisi di 51 polimorfismi in 35 geni dell’infiammazione per la valutazione del rischio di coronaropatia e di infarto del miocardio 207
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 205
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 204
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 203
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 202
A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist 202
A common polymorphism in LDL-receptor gene is a predictor of factor VIII activity and is associated with coronary artery disease. 200
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 199
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 196
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 194
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 194
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 191
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 190
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 190
Reply to Novelli 189
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 189
Altered paraoxonase expression in patients with genetic haemochromatosis. 189
Air particulate matter and cardiovascular disease: a narrative review. 186
Efficacy of tacrolimus ointment in nickel sulphate allergic contact dermatitis 185
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 185
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 185
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 185
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 184
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 183
Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. 182
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 182
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 182
[Genetic risk factors in ischemic cardiopathy] 182
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 182
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus 181
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 181
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 180
A common polymorphism in low-density lipoprotein receptor gene is a predictor of factor VIII activity levels and is associated with coronary artery disease. 180
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 180
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 180
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 179
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 178
A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: Relationships with C677T polymorphism and homocysteine/folate metabolism 177
Adults with moderate to severe clesquarnative gingivitis: A 4-week, randomized, single blind, clinical trial. Comparison of topical tacrolimus 0.1% in orabase with clobetasol 0.5% ointment 176
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 175
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. 175
Paraoxonase-1 status in patients with hereditary hemochromatosis 175
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 173
Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. 172
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 172
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 172
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 170
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 170
Determinants of serum ferritin in the metabolic syndrome. 170
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 170
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 169
Detection of a large deletion in the P-selectin (SELP) gene 169
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment 168
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 168
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 168
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 168
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 167
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 167
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 167
Nichel sulphate intollerance in oral lichen planus 166
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 166
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 166
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 165
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 165
A dangerous onychodystrophy 165
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 164
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 164
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 163
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 163
Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Coronary Artery Disease and in Centenarians. Further Clues Linking Chip with Cardiovascular Risk 163
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 162
Severity of lung impairment in scleroderma is related to homocysteine plasma concentration. 162
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 162
Double-blind placebo-controlled challange with nickle salts in patients affected by recurrent aphtous stomatitis 161
Prevalence of body iron excess in the metabolic syndrome. 161
SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease 161
Totale 19.092
Categoria #
all - tutte 136.997
article - articoli 87.324
book - libri 0
conference - conferenze 48.732
curatela - curatele 0
other - altro 360
patent - brevetti 0
selected - selezionate 0
volume - volumi 581
Totale 273.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 0 0 93
2021/20222.016 137 497 21 168 101 72 29 107 93 66 201 524
2022/20234.630 350 422 486 790 459 1.050 37 306 540 29 96 65
2023/20242.408 98 169 191 237 286 469 69 192 17 80 363 237
2024/20255.663 314 410 175 956 244 201 293 222 805 331 489 1.223
2025/202616.901 1.258 854 1.230 2.799 4.269 1.169 1.506 847 1.343 877 276 473
Totale 42.150